Selbyville, Delaware, April 25, 2019 (GLOBE NEWSWIRE) --
The U.S. diabetes care devices market is set to exceed USD 14.5 billion by 2025 owing to increasing incidence of target diseases and rising adoption of sedentary lifestyle. Increasing healthcare spending coupled with technological advancements in diabetes care devices should stimulate U.S. market growth.
Global Diabetes Care Devices Market is poised to surpass USD 41.5 billion by 2025; according to a new research report by Global Market Insights, Inc. Obesity is a primary driver for growing prevalence of diabetes. Increasing adoption of unhealthy diet, growing alcohol consumption and tobacco smoking coupled with physical inactivity has escalated obese population base to a great extent. As per the Pan American Health Organization (PAHO), nearly 305,000 people died due to type 2 diabetes in America in the year 2014, hence propelling the market growth.
Technological advancements in devices used for monitoring blood glucose levels and insulin delivery will drive diabetes care devices market over the forecast timeframe. Growing population of health-conscious people adopting continuous glucose monitoring devices and rising awareness regarding body weight management will positively impact global diabetes care devices industry growth.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3250
Several initiatives undertaken by organizations such as the International Diabetes Federation (IDF) to create awareness regarding diabetes care should positively impact market growth. However, lack of reimbursement and insurance coverage along with low per capita spending on diabetes management will hamper diabetes care devices business to a certain extent over the coming years.
Browse key industry insights spread across 260 pages with 360 market data tables & 7 figures & charts from the report, “Diabetes Care Devices Market By Products (Blood Glucose Monitoring Devices {Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets}, Insulin Delivery Devices {Insulin Pumps [Tubed Pumps, Tubeless Pumps], Pens [Reusable, Disposable], Pen Needles [Standard, Safety], Syringes), By End-use (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers, Home Care), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, The Netherlands, Sweden, Belgium, Denmark, Finland, Norway, Lithuania, Latvia, Estonia, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/diabetes-care-devices-market
Blood glucose monitoring devices product segment accounted for more than 60% market share in 2018 and is projected to witness considerable growth over the forecast period. Rising awareness regarding diabetes management, and growing number of health-conscious people leading to high adoption of diabetes monitoring devices should drive blood glucose monitoring devices market.
Homecare end-use segment will witness 6.4% CAGR during the forecast period. Skyrocketing growth of home healthcare sector, development of user-friendly and affordable devices along with rising prevalence of diabetes will favor homecare diabetes care devices market growth during the forecast timeframe.
China held more than 30% market share of Asia Pacific diabetes care devices market in 2018. Nearly 10.9% total adult population of China suffer from diabetes, as per the IDF. High prevalence of diabetes, increasing rates of obesity and overweight along with physical inactivity will drive China market over the coming years.
Few notable players operating in diabetes care devices market are Abbott Laboratories, B. Braun Melsungen AG, Bayer Corporation, Roche among others. Companies are currently focusing on developing innovative and user-friendly diabetes management devices that are cost-effective as well as efficient. Market players are resorting to strategies such as partnerships and strategic collaborations with other participants in value chain to expand consumer base and gain competitive edge over other companies functioning in the market.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3250
Browse Related Reports:
Antidiabetics Market By Products (Insulin [Rapid Acting, Long Acting, Premixed Insulin, Short Acting, Intermediate Acting], Drug Class [Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 Agonist, Meglitinides, DPP-4 Inhibitors, SGLT-2, Thiazolidinedione]), By Patient Population (Pediatric, Adult, Geriatric), By Route Of Administration (Insulin Syringe/Insulin Pen, Insulin Pump, Intravenous Infusion, Oral) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024
https://www.gminsights.com/industry-analysis/antidiabetics-market
Diabetic Retinopathy Market By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy), By Age Group (40-49, 50-64, 65-74), By Management (Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Distribution Channel (Hospitals & Pharmacies, Eye Clinics, Ambulatory Surgical Centers (ASCs)), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025
https://www.gminsights.com/industry-analysis/diabetic-retinopathy-market-report
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.